Shoumeng Han

1.2k total citations
13 papers, 188 citations indexed

About

Shoumeng Han is a scholar working on Neurology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Shoumeng Han has authored 13 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Shoumeng Han's work include Intracranial Aneurysms: Treatment and Complications (5 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Shoumeng Han is often cited by papers focused on Intracranial Aneurysms: Treatment and Complications (5 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Shoumeng Han collaborates with scholars based in China, Japan and United States. Shoumeng Han's co-authors include Mingchang Li, Qi Tian, Qianxue Chen, Jianming Liao, Ling Gao, Xu Zhou, Chengli Liu, Qi Tian, Guijun Wang and Junhui Chen and has published in prestigious journals such as Biochemical Pharmacology, European Journal of Pharmacology and Frontiers in Pharmacology.

In The Last Decade

Shoumeng Han

12 papers receiving 188 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoumeng Han China 7 70 60 42 27 26 13 188
Qing Lv China 8 127 1.8× 32 0.5× 27 0.6× 24 0.9× 51 2.0× 12 281
Lingui Gu China 9 125 1.8× 42 0.7× 90 2.1× 25 0.9× 16 0.6× 21 264
Frank Yi United States 8 168 2.4× 42 0.7× 86 2.0× 43 1.6× 38 1.5× 11 288
Ronglan Zhu China 10 182 2.6× 35 0.6× 41 1.0× 42 1.6× 87 3.3× 17 338
Shirley D. Wenker Argentina 8 128 1.8× 33 0.6× 19 0.5× 19 0.7× 11 0.4× 11 298
Guangyong Wu China 9 107 1.5× 26 0.4× 89 2.1× 27 1.0× 37 1.4× 16 260
Lars Björn Riecken Germany 6 94 1.3× 21 0.3× 49 1.2× 15 0.6× 11 0.4× 9 224
Yueran Cui China 8 199 2.8× 67 1.1× 26 0.6× 26 1.0× 95 3.7× 10 311
Yimeng Xue China 7 132 1.9× 101 1.7× 36 0.9× 23 0.9× 63 2.4× 8 271
Zexuan Hong China 8 123 1.8× 43 0.7× 9 0.2× 11 0.4× 46 1.8× 11 197

Countries citing papers authored by Shoumeng Han

Since Specialization
Citations

This map shows the geographic impact of Shoumeng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoumeng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoumeng Han more than expected).

Fields of papers citing papers by Shoumeng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoumeng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoumeng Han. The network helps show where Shoumeng Han may publish in the future.

Co-authorship network of co-authors of Shoumeng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Shoumeng Han. A scholar is included among the top collaborators of Shoumeng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoumeng Han. Shoumeng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ma, Li, Weiliang Zeng, Kun Song, et al.. (2025). Splenic γδ T cells are required for vagotomy-mediated protection against LPS-induced depression- and anxiety-like behaviors through the spleen-brain axis. Biochemical Pharmacology. 240. 117094–117094. 1 indexed citations
2.
Han, Shoumeng, Tingting Xie, Kun Song, et al.. (2025). AdipoRon ameliorates anxiety- and depression-like behaviors in chronic restraint-stressed mice via AMPK-PPARα-BDNF-TrkB signaling. European Journal of Pharmacology. 1011. 178468–178468.
3.
Tian, Qi, Shoumeng Han, Sheng Liu, et al.. (2023). Low Wall Shear Stress and High Intra-aneurysmal Pressure are Associated with Ruptured Status of Vertebral Artery Dissecting Aneurysms. CardioVascular and Interventional Radiology. 46(2). 240–248. 3 indexed citations
4.
Han, Shoumeng, Wei Zhang, Qi Tian, et al.. (2023). Advantages of computed tomography-based navigation in clipping distal anterior cerebral artery aneurysms: a retrospective cohort study. Quantitative Imaging in Medicine and Surgery. 13(12). 8326–8335. 1 indexed citations
5.
Tian, Qi, Sheng Liu, Shoumeng Han, et al.. (2022). The mechanism and relevant mediators associated with neuronal apoptosis and potential therapeutic targets in subarachnoid hemorrhage. Neural Regeneration Research. Publish Ahead of Print(2). 244–252. 23 indexed citations
6.
7.
Liu, Chengli, Qi Tian, Jianfeng Wang, et al.. (2022). Blocking P2RX7 Attenuates Ferroptosis in Endothelium and Reduces HG-induced Hemorrhagic Transformation After MCAO by Inhibiting ERK1/2 and P53 Signaling Pathways. Molecular Neurobiology. 60(2). 460–479. 28 indexed citations
8.
Han, Shoumeng, Qi Tian, Guijun Wang, et al.. (2022). Diabetes or calcium channel blocker contribute to cerebral hemodynamics after bypass surgery in adult patients with moyamoya disease. Quantitative Imaging in Medicine and Surgery. 13(1). 293–308. 1 indexed citations
9.
Zhang, Wei, Qi Tian, Shoumeng Han, et al.. (2022). The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway. Journal of Oncology. 2022. 1–10. 13 indexed citations
10.
Zhang, Wei, Qi Tian, Shoumeng Han, et al.. (2022). Efficacy and safety of embolization for arteriovenous malformations of the basal ganglia and thalamus via the transarterial approach. Annals of Translational Medicine. 10(6). 306–306. 5 indexed citations
11.
12.
Gao, Lun, Junhui Liu, Pengfei Xu, et al.. (2020). AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway. Frontiers in Pharmacology. 11. 1102–1102. 17 indexed citations
13.
Tian, Qi, Shoumeng Han, Xu Zhou, et al.. (2019). Tetramethylpyrazine attenuates blood-brain barrier disruption in ischemia/reperfusion injury through the JAK/STAT signaling pathway. European Journal of Pharmacology. 854. 289–297. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qing Lv Breakdown of academic impact, for papers by Lingui Gu Breakdown of academic impact, for papers by Frank Yi Breakdown of academic impact, for papers by Ronglan Zhu Breakdown of academic impact, for papers by Shirley D. Wenker Breakdown of academic impact, for papers by Guangyong Wu Breakdown of academic impact, for papers by Lars Björn Riecken Breakdown of academic impact, for papers by Yueran Cui Breakdown of academic impact, for papers by Yimeng Xue Breakdown of academic impact, for papers by Zexuan Hong
Rankless by CCL
2026